MiR-590 suppresses the progression of non-small cell lung cancer by regulating YAP1 and Wnt/β-catenin signaling

被引：0
|
作者：
X. Hao
A. Su
机构：
[1] National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Department of Internal Medicine
[2] Chinese Academy of Medical Science and Peking Union Medical College,General Department
[3] Bejing Chaoyang District Sanhuan Cancer Hospital,undefined
来源：
Clinical and Translational Oncology | 2022年 / 24卷
关键词：
miR-590; NSCLC; YAP1; Wnt/β-catenin; Progression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：546 / 555
页数：9
相关论文
共 50 条
  • [31] MiR-924 as a tumor suppressor inhibits non-small cell lung cancer by inhibiting RHBDD1/Wnt/β-catenin signaling pathway
    Wang, Huaishi
    Chen, Xi
    Yang, Baishuang
    Xia, Zhi
    Chen, Qiong
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [32] Synergistic effects of dual inhibition of YAP1 and TAZ in non-small cell lung cancer cells
    Shum, Elaine
    Liu, Huijie
    Zhu, Liang
    Perez-Soler, Roman
    Halmos, Balazs
    Cheng, Haiying
    CANCER RESEARCH, 2017, 77
  • [33] MicroRNA-590-5p suppresses the proliferation and invasion of non-small cell lung cancer by regulating GAB1
    Xu, B. -B.
    Gu, Z. -F.
    Ma, M.
    Wang, J. -Y.
    Wang, H. -N.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (18) : 5954 - 5963
  • [34] Re: The Wnt Signaling Pathway in Non-Small Cell Lung Cancer
    Hubaux, Roland
    Thu, Kelsie L.
    Lam, Wan L.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (08):
  • [35] Wnt signaling pathway pharmacogenetics in non-small cell lung cancer
    Stewart, D. J.
    Chang, D. W.
    Ye, Y.
    Spitz, M.
    Lu, C.
    Shu, X.
    Wampfler, J. A.
    Marks, R. S.
    Garces, Y. I.
    Yang, P.
    Wu, X.
    PHARMACOGENOMICS JOURNAL, 2014, 14 (06): : 509 - 522
  • [36] IGF2BP1 facilitates non-small cell lung cancer progression by regulating the KIF2A-mediated Wnt/β-catenin pathway
    Sun, Ming
    Wang, Ling
    Ge, Lei
    Xu, Daojun
    Zhang, Renquan
    FUNCTIONAL & INTEGRATIVE GENOMICS, 2024, 24 (01)
  • [37] IGF2BP1 facilitates non-small cell lung cancer progression by regulating the KIF2A-mediated Wnt/β-catenin pathway
    Ming Sun
    Ling Wang
    Lei Ge
    Daojun Xu
    Renquan Zhang
    Functional & Integrative Genomics, 2024, 24
  • [38] Wnt signaling pathway pharmacogenetics in non-small cell lung cancer
    D J Stewart
    D W Chang
    Y Ye
    M Spitz
    C Lu
    X Shu
    J A Wampfler
    R S Marks
    Y I Garces
    P Yang
    X Wu
    The Pharmacogenomics Journal, 2014, 14 : 509 - 522
  • [39] The role of YAP signaling in KRAS driven non-small cell lung cancer
    Keil, Marina
    Schneider, Richard
    Trivier, Elisabeth
    Dillon, Christian
    Wienke, Dirk
    Seshire, Anita
    Pudelko, Linda
    Blaukat, Andree
    Karachaliou, Niki
    CANCER RESEARCH, 2020, 80 (16)
  • [40] Long Noncoding RNA DANCR Activates Wnt/β-Catenin Signaling through MiR-216a Inhibition in Non-Small Cell Lung Cancer
    Yu, Justine E.
    Ju, Julia A.
    Musacchio, Nicholas
    Mathias, Trevor J.
    Vitolo, Michele I.
    BIOMOLECULES, 2020, 10 (12) : 1 - 18
12345